Sanofi Receives FDA Approval of Soliqua 100/33 for the Treatment of Adults with Type 2 Diabetes
Sanofi announced that the U.S. FDA approved once-daily Soliqua 100/33 100 Units/mL & 33 mcg/mL for the treatment of adults with type 2 diabetes...
Sandoz’s Erelzi receives FDA Approval making it the First US Enbrel Biosimilar
Sandoz, a Novartis company, has announced its drug, Erelzi, has been approved by the FDA, in a significant development. ...
Teva Secures EU Approval of Trisenox for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia
Teva Pharmaceutical Industries Ltd announced it has obtained approval from the European Commission for an indication extension of Trisenox® (arsenic trioxide). This marks an...
Spark Therapeutics and Pfizer receives FDA Designation for SPK-9001
Spark Therapeutics and Pfizer Inc announced that the U.S. FDA has granted breakthrough therapy designation to SPK-9001, the lead investigational candidate in the companies’...
Sandoz Biosimilar Etanercept Recommended By Fda For Approval To Treat Multiple Inflammatory Diseases
Sandoz, a Novartis division and leader in biosimilars, announced today that the US FDA Advisory Committee recommended approval of its proposed biosimilar etanercept.
The...
U.S. FDA Grants Priority Review to Janssen’s New Drug Application for Chewable Mebendazole Tablets
Janssen Pharmaceuticals, Inc one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced today that the U.S. Food and Drug Administration (FDA)...
US FDA approves expanded label for self-infusion of Glassia to treat emphysema due to severe AAT deficiency
Shire plc and Kamada Ltd a plasma-derived protein therapeutics company focused on orphan indications, announced that the US FDA has approved an expanded label...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...